Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FL2B6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,504
Award facts
- Contract value 100% obligated
- $44,504.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44.5K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The award, issued on September 19, 2025, carries an ultimate completion date of October 10, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively across a robust portfolio of medical product deliveries to the Department of Defense. The company's contract history demonstrates consistent success in securing pharmaceutical delivery orders covering diverse product categories including prescription medications, biologics, vaccines, and specialty therapeutics. This particular award for Entyvio, an injectable biologic medication, reflects the company's continued role in supporting military healthcare system medication requirements across the nation.
Quick answers
Who was awarded contract SPE2DB25FL2B6?
SPE2DB25FL2B6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FL2B6 worth?
The government has obligated $44,504 on SPE2DB25FL2B6.
Is contract SPE2DB25FL2B6 an order under another contract?
Yes. SPE2DB25FL2B6 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL2B6 competed?
The extent of competition for SPE2DB25FL2B6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award